Literature DB >> 15163726

Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity.

Daisuke Sugahara1, Sachiyo Tsuji-Kawahara, Masaaki Miyazawa.   

Abstract

Recent studies have demonstrated an essential role of Gag-specific CD4+ T-cell responses for viral control in individuals infected with human immunodeficiency virus type 1. However, little is known about epitope specificities and functional roles of the Gag-specific helper T-cell responses in terms of vaccine-induced protection against a pathogenic retroviral challenge. We have previously demonstrated that immunization with Friend murine leukemia virus (F-MuLV) Gag proteins protects mice against the fatal Friend retrovirus (FV) infection. We report here the structure of a protective T helper cell (Th) epitope, (I)VTWEAIAVDPPP, identified in the p15 (MA) region of F-MuLV Gag. In mice immunized with the Th epitope-harboring peptide or a vaccinia virus-expressed native full-length MA protein, FV-induced early splenomegaly regressed rapidly. In these mice, FV-infected cells were eliminated within 4 weeks and the production of virus-neutralizing antibodies was induced rapidly after FV challenge, resulting in strong protection against the virus infection. Interestingly, mice immunized with the whole MA mounted strong CD4+ T-cell responses to the identified Th epitope, whereas mice immunized with mutant MA proteins that were not bound to the plasma membrane failed to mount efficient CD4+ T-cell responses, despite the presence of the Th epitope. These mutant MA proteins also failed to induce strong protection against FV challenge. These data indicate the importance of the properly processible MA molecule for CD4+ T-cell priming and for the resultant induction of an effective immune response against retrovirus infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163726      PMCID: PMC416509          DOI: 10.1128/JVI.78.12.6322-6334.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression.

Authors:  C J Pitcher; C Quittner; D M Peterson; M Connors; R A Koup; V C Maino; L J Picker
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

2.  Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection.

Authors:  S McAdam; P Kaleebu; P Krausa; P Goulder; N French; B Collin; T Blanchard; J Whitworth; A McMichael; F Gotch
Journal:  AIDS       Date:  1998-04-16       Impact factor: 4.177

Review 3.  CD4+ T-cell induction and effector functions: a comparison of immunity against soluble antigens and viral infections.

Authors:  A Oxenius; R M Zinkernagel; H Hengartner
Journal:  Adv Immunol       Date:  1998       Impact factor: 3.543

4.  Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients.

Authors:  D Durali; J Morvan; F Letourneur; D Schmitt; N Guegan; M Dalod; S Saragosti; D Sicard; J P Levy; E Gomard
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

Authors:  J E Schmitz; M J Kuroda; S Santra; V G Sasseville; M A Simon; M A Lifton; P Racz; K Tenner-Racz; M Dalesandro; B J Scallon; J Ghrayeb; M A Forman; D C Montefiori; E P Rieber; N L Letvin; K A Reimann
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

6.  A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers.

Authors:  O Planz; S Ehl; E Furrer; E Horvath; M A Bründler; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

7.  Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors.

Authors:  W Chen; H Qin; B Chesebro; M A Cheever
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

8.  Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.

Authors:  E S Rosenberg; J M Billingsley; A M Caliendo; S L Boswell; P E Sax; S A Kalams; B D Walker
Journal:  Science       Date:  1997-11-21       Impact factor: 47.728

9.  Overlapping epitopes of friend murine leukemia virus gag-encoded leader sequence recognized by single cytotoxic T-lymphocyte clones.

Authors:  H Uenishi; N Iwanami; K Kuribayashi; H Tamamura; N Fujii; T Nakatani; T Kawasaki; H Yamagishi
Journal:  Immunol Lett       Date:  1998-05       Impact factor: 3.685

10.  Viral immune evasion due to persistence of activated T cells without effector function.

Authors:  A J Zajac; J N Blattman; K Murali-Krishna; D J Sourdive; M Suresh; J D Altman; R Ahmed
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

View more
  7 in total

1.  Contribution of virus-like particles to the immunogenicity of human immunodeficiency virus type 1 Gag-derived vaccines in mice.

Authors:  S B Justin Wong; Robert F Siliciano
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

2.  Natural killer cells recognize friend retrovirus-infected erythroid progenitor cells through NKG2D-RAE-1 interactions In Vivo.

Authors:  Tatsuya Ogawa; Sachiyo Tsuji-Kawahara; Takae Yuasa; Saori Kinoshita; Tomomi Chikaishi; Shiki Takamura; Haruo Matsumura; Tsukasa Seya; Toshihiko Saga; Masaaki Miyazawa
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

3.  Persistence of viremia and production of neutralizing antibodies differentially regulated by polymorphic APOBEC3 and BAFF-R loci in friend virus-infected mice.

Authors:  Sachiyo Tsuji-Kawahara; Tomomi Chikaishi; Eri Takeda; Maiko Kato; Saori Kinoshita; Eiji Kajiwara; Shiki Takamura; Masaaki Miyazawa
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

4.  Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo.

Authors:  Eri Takeda; Sachiyo Tsuji-Kawahara; Mayumi Sakamoto; Marc-André Langlois; Michael S Neuberger; Cristina Rada; Masaaki Miyazawa
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

5.  Mice of the resistant H-2(b) haplotype mount broad CD4(+) T cell responses against 9 distinct Friend virus epitopes.

Authors:  Ronald J Messer; Kerry J Lavender; Kim J Hasenkrug
Journal:  Virology       Date:  2014-04-05       Impact factor: 3.616

6.  Targeting viral antigens to CD11c on dendritic cells induces retrovirus-specific T cell responses.

Authors:  Asim Ejaz; Christoph G Ammann; Roland Werner; Georg Huber; Verena Oberhauser; Susanne Hörl; Simone Schimmer; Ulf Dittmer; Dorothee von Laer; Heribert Stoiber; Zoltán Bánki
Journal:  PLoS One       Date:  2012-09-17       Impact factor: 3.240

Review 7.  Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model.

Authors:  Savita Nair; Wibke Bayer; Mickaël J Y Ploquin; George Kassiotis; Kim J Hasenkrug; Ulf Dittmer
Journal:  Retrovirology       Date:  2011-09-26       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.